The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.
PU.1 (Spi-1) and C/EBPα Regulate Expression of the Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Gene
Open accessAbstract
Growth factor receptors play an important role in hematopoiesis. In order to further understand the mechanisms directing the expression of these key regulators of hematopoiesis, we initiated a study investigating the transcription factors activating the expression of the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor alpha gene. Here, we demonstrate that the human GM-CSF receptor alpha promoter directs reporter gene activity in a tissue-specific fashion in myelomonocytic cells, which correlates with its expression pattern as analyzed by reverse transcription PCR. The GM-CSF receptor alpha promoter contains an important functional site between positions -53 and -41 as identified by deletion analysis of reporter constructs. We show that the myeloid and B cell transcription factor PU.1 binds specifically to this site. Furthermore, we demonstrate that a CCAAT site located upstream of the PU.1 site between positions -70 and -54 is involved in positive-negative regulation of the GM-CSF receptor alpha promoter activity. C/EBP alpha is the major CCAAT/enhancer-binding protein (C/EBP) form binding to this site in nuclear extracts of U937 cells. Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only. Furthermore, we demonstrate that in myeloid and B cell extracts, PU.1 forms a novel, specific, more slowly migrating complex (PU-SF) when binding the GM-CSF receptor alpha promoter PU.1 site. This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site. The novel complex is distinct from that described previously as binding to B cell enhancer sites and can be formed by addition of PU.1 to extracts from certain nonmyeloid cell types which do not express PU.1, including T cells and epithelial cells, but not from erythroid cells. Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters, and its formation requires an intact PU.1 site adjacent to a single-stranded region. Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter. Deletion of the amino-terminal region of PU.1 results in a failure to form the PU-SF complex and in a concomitant loss of transactivation, suggesting that formation of the PU-SF complex is of functional importance for the activity of the GM-CSF receptor alpha promoter. Finally, we demonstrate that C/EBP alpha can also active the GM-CSF receptor alpha promoter in nonmyeloid cells. These results suggest that PU.1 and C/EBP alpha direct the cell-type-specific expression of GM-CSF receptor alpha, further establish the role of PU.1 as a key regulator of hematopoiesis, and point to C/EBP alpha as an additional important factor in this process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PU.1 imparts its key functions by regulating vast number of myeloid gene promoters that include GM-CSF receptor a, M-CSF receptor (M-CSFR), scavenger receptor CD163, and CD11b, etc (6,7).”
From FBW7 Inhibits Myeloid Differentiation in Acute Myeloid Leukemia via GSK3-Dependent Ubiquitination of PU.1 (2021) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In cotransfection experiments, RUNX1, PU.1, and CEBPA play essential roles in activation of the hematopoietic differentiation genes MCSFR and GMCSFR.7,8,31”
From RUNX1 regulates corepressor interactions of PU.1 (2011) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The block in the development of these lineages occurs at very early stages, because the mutant animals completely lack lymphoid and myeloid progenitor cells, rendering it difficult to determine the precise role of PU.1 during stage- and lineage-specific gene expression.”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [67]
Experimental — accuracy not yet measuredIn the citing paper
“In myeloid lineages, the putative PU.1 target genes include G-SCF receptor [23], GM-CSF receptor [24] and M-CSF receptor [25].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [24]
In the citing paper
“C/EBP-α expression is prominent in immature myeloid cells [24, 101].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [24]
In the citing paper
“Each factor has been shown to synergize on various promoters, including M-CSF receptor promoter and neutrophil elastase (NE) promoter [24, 63].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [24]
In the citing paper
“C/EBP-␣ minimally activates several myeloid cell-specific promoters, including those for cytokine receptors (e.g., GM-CSF, G-CSF, and M-CSF receptors) (26,65,78,79) and granule proteins (e.g., NE) (50).”
From The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation (1998) · cites this paper as [26]
In the citing paper
“Moreover, C/EBP-␣ cooperates with other myeloid transcription factors, including AML-1B and PU.1, to synergistically upregulate the expression of several myeloid cellspecific promoters (26,50,78).”
From The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation (1998) · cites this paper as [26]
In the citing paper
“Each factor has been shown to synergize on various promoters, including M-CSF receptor promoter and neutrophil elastase promoter.15,35”
From Granulocyte inducer C/EBPα inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions (2002) · cites this paper as [15]
In the citing paper
“Targeted disruption of PU.1 in mice severely impairs the development of lymphoid (B cells) and myeloid (macrophages and neutrophils) lineages.”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular cloning: A laboratory manual
Deininger, P. L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,684
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,262
A new method for sequencing DNA.
Maxam, A. M., & Gilbert, W. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.2.560 · Cited by 7,929
Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.
Cao, Z., Umek, R. M., & McKnight, S. L. (1991) · Genes & Development · doi:10.1101/gad.5.9.1538 · Cited by 1,663
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
EUKARYOTIC TRANSCRIPTIONAL REGULATORY PROTEINS
Johnson, P. F., & McKnight, S. L. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.004055 · Cited by 1,210
Luciferase reporter gene vectors for analysis of promoters and enhancers.
Nordeen, S. K. (1988) · PubMed · Cited by 994
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954
Expression cloning of a receptor for human granulocyte‐macrophage colony‐stimulating factor.
Gearing, D. P., King, J. A., Gough, N. M., & Nicola, N. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08541.x · Cited by 683
A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes
Staudt, L. M., Singh, H., Sen, R., Wirth, T. C., Sharp, P. A., & Baltimore, D. (1986) · Nature · doi:10.1038/323640a0 · Cited by 658
Flagged first, then by citations
1 of the 73 references couldn’t be matched to a known paper.
Research works printed but not linked: 13
- Eisenbeis C. F., 1993, Mol. Cell. Biol., 13, 6452
- Emanuel P. D., 1991, Exp. Hematol., 19, 1017
- 10.1182/blood.V82.7.1960.1960 · DOI
- Moulton K. S., 1994, Mol. Cell. Biol., 14, 4408
- Nordeen S. K., 1988, BioTechniques, 6, 454
- 10.1128/mcb.14.8.5558-5568.1994 · DOI · Paper page
- Pahl H. L., 1991, Exp. Hematol., 19, 1038
- Perez C., 1994, Mol. Cell. Biol., 14, 5023
- Pongubala J. M., 1992, Mol. Cell. Biol., 12, 368
- Ray D., 1992, Mol. Cell. Biol., 12, 4297
- Schuetze S., 1992, Mol. Cell. Biol., 12, 2967
- Schuetze S., 1993, Mol. Cell. Biol., 13, 5670
- Zhang D. E., 1994, Mol. Cell. Biol., 14, 8085
Cited by
Sorted by citations
Items 201–286 of 286
Trinh, B. Q., Barengo, N., Kim, S. B., Lee, J., Zweidler‐McKay, P. A., & Naora, H. (2015) · Journal of Cell Science · doi:10.1242/jcs.168187 · Cited by 18
“To assay BFU-E, CFU-GM and CFU-GEMM formation, transduced CD34+ cells were sorted for GFP using a FACS AriaII cell sorter (BD Biosciences) and then seeded in low-adherence dishes that contained methylcellulosebased semi-solid medium supplemented with SCF, EPO, GM-CSF, G-GSF and IL-3 (MethoCult™ H4034 Optimum, Stem Cel…”
BackgroundGross, S. A., Zheng, J. H., Le, A. T., Kerzic, P. J., & Irons, R. (2006) · Cell Biology and Toxicology · doi:10.1007/s10565-006-0128-7 · Cited by 18
“CD34+ HPC undergo lineage commitment and differentiation when cultured in the presence of cytokines such as GM-CSF, IL-3, and SCF, all of which support CD34+ HPC growth and development as well as others that stimulate terminal differentiation (e.g., GM-CSF, Epo, M-CSF, G-CSF).”
InfluentialBarbara, A., Katakura, F., & Belosevic, M. (2012) · InTech eBooks · doi:10.5772/53589 · Cited by 16
“Mice deficient in PU.1 (PU.1-/-) have reduced CLPs, and GMPs, increased numbers of MEPs, and lack B- New Advances and Contributions to Fish Biology110 cells, T-cells, monocytes/macrophages as well as severely reduced numbers of granulocytes [186-190].”
BackgroundInfluentialFino, K. K., Yang, L., Silveyra, P., Hu, S., Umstead, T. M., DiAngelo, S. L., Halstead, E. S., Cooper, T. K., Abraham, T., Takahashi, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07724-5 · Cited by 16
“The CCAAT/enhancer binding protein genes Cebpd, Cebpb, and Cebpa have crucial roles as pioneer transcription factors in both lung epithelial and immune cell regulating lung structure integrity, regeneration, differentiation, and surfactant related gene expression through interaction with tissue and cell specific trans…”
Transcriptionally imprinted glycomic signatures of acute myeloid leukemia
Blöchl, C., Wang, D., Mayboroda, O. A., Lageveen‐Kammeijer, G. S. M., & Wuhrer, M. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00981-0 · Cited by 16
Wei, R., Dhawan, P., Baiocchi, R. A., Kim, K., & Christakos, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27702 · Cited by 15
“immunity and hematopoiesis including granulocyte macrophage colony stimulating factor receptor and interleukin‐1β (IL‐1β; Hohaus et al., 1995; Yang, Wara‐Aswapati, Chen, Tsukada, & Auron, 2000).”
BackgroundInfluentialMi, J., Hooker, E., Balog, S., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005395 · Cited by 15
Yao, S., Chen, X., Chen, J., Guan, Y., Liu, Y., Chen, J., & Lv, X. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0711-z · Cited by 15
“As a well-known transcription factor, C/EBPα induces the transcription of several lineage-specific genes, such as G-CSF-R [24] and PPARγ [25].”
BackgroundBMP signaling balances murine myeloid potential through SMAD-independent p38MAPK and NOTCH pathways
Cook, B. D., & Evans, T. (2014) · Blood · doi:10.1182/blood-2014-02-556993 · Cited by 15
Tissières, P., Araud, T., Ochoda, A., Drifte, G., Dunn-Siegrist, I., & Pugin, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042580 · Cited by 15
Chiang, M. Y., & Monroe, J. (2001) · Journal of Immunology · doi:10.4049/jimmunol.166.10.6091 · Cited by 16
PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner
Houston, I. B., Huang, K. J., Jennings, S. R., & DeKoter, R. P. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2006.11.003 · Cited by 15
Qian, M., Jin, W. Y., Zhu, X., Jia, X., Yang, X., Du, Y., Wang, K., & Zhang, J. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-25 · Cited by 14
Kim, J. C., Jung, Y. S., Lee, H. Y., Park, J. S., & Bae, Y. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.120 · Cited by 14
PU.1 regulates the expression of the Vav proto‐oncogene
Denkinger, D. J., Lambrecht, T. Q., Cushman‐Vokoun, A. M., & Kawahara, R. S. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10089 · Cited by 14
Structural and Functional Studies of CCAAT/Enhancer-binding Protein ε
Tang, J., & Koeffler, H. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011546200 · Cited by 14
Aldahl, J., Mi, J., Pineda, A., Kim, W. K., Olson, A. W., Hooker, E., He, Y., Yu, E., Le, V. L., Lee, D.-H., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011137 · Cited by 13
Human monocyte/neutrophil elastase inhibitor (MNEI) is regulated by PU.1/SPI-1, SP1, and NF-?B
Zeng, W., & Remold‐O’Donnell, E. (2000) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20000915)78:4 · Cited by 13
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
Ji, Y., He, R., & Alkhateeb, H. B. (2023) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-023-00699-3 · Cited by 11
IL-32α down-regulates β2 integrin (CD18) expression by suppressing PU.1 expression in myeloid cells
Kang, J.-W., Park, Y. S., Kim, M. S., Lee, D. H., Bak, Y., Ham, S. Y., Song, Y., Hong, J. T., & Yoon, D. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.03.027 · Cited by 11
Uchiumi, F., Enokida, K., Shiraishi, T., Masumi, A., & Tanuma, S.-I. (2010) · Gene · doi:10.1016/j.gene.2010.04.014 · Cited by 11
B Lymphocyte Development and Transcription Regulation in Vivo
Opstelten, D. (1996) · Advances in immunology · doi:10.1016/s0065-2776(08)60857-3 · Cited by 10
Shikama, Y., Shichishima, T., Ohto, H., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02398.x · Cited by 10
NPM1 mutation reprograms leukemic transcription network via reshaping TAD topology
Lai, Q., Hamamoto, K., Luo, H., Zaroogian, Z., Zhou, C., Lesperance, J., Zha, J., Qiu, Y., Guryanova, O. A., Huang, S., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01942-9 · Cited by 10
Introduction and Classification of Leukemias
Brown, G. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0810-4_1 · Cited by 9
Analysis of the 5′ promoters for human IL-3 and GM-CSF receptor α genes
Akagawa, E., Muto, A., Arai, K., & Watanabe, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02890-5 · Cited by 8
Almaghrabi, R. O. M., Alyahyawi, Y., Keane, P., Mian, S. A., Habel, K., Atkinson, A., Ward, C., Bayley, R., Sargas, C., Menéndez, P. R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60192-8 · Cited by 8
“In agreement with the essential role of C/EBP α in the formation of granulocyte progenitors 74,75 , neither CFU-G nor mature granulocytes were detected in colony assays or liquid cultures, respectively.”
The versatility of haematopoietic stem cells: implications for leukaemia
Brown, G., Hughes, P., Michell, R. H., & Ceredig, R. (2010) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2010.530150 · Cited by 7
Chen, Y., Huang, J., Guo, Z., Zhu, Z., Shao, Y., Li, L., Yang, Y., Yu, Y., Liu, L., & Sun, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.970909 · Cited by 7
“CEBPA played an important role in regulating neutrophil lineage and early differentiation, and CEBPE was also involved in the formation of specific particles and gelatinase particles (19, 20).”
BackgroundPU.1, a Shared Transcriptional Regulator of Innate and Adaptive Immune Cell Fates
Singh, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1595 · Cited by 7
Dannaeus, K., Bessonova, M., & Jönsson, J. (2005) · Molecular Biology Reports · doi:10.1007/s11033-005-0753-x · Cited by 8
Iwamoto, T., Senga, T., Adachi, K., & Hamaguchi, M. (2003) · Cytokine · doi:10.1016/j.cyto.2003.10.009 · Cited by 7
Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia
Mueller, B. U., Pabst, T., Hauser, P., Gilliland, G. D., Neuberg, D. S., & Tenen, D. G. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603198 · Cited by 6
GD1a modulates GM-CSF-induced cell proliferation
Santos, A. X. S., Maia, J. E., Crespo, P. M., et al. (2011) · Cytokine · doi:10.1016/j.cyto.2011.08.032 · Cited by 6
TLR Activation Alters Bone Marrow-Derived Macrophage Differentiation
Oppong-Nonterah, G. O., Lakhdari, O., Yamamura, A., Hoffman, H. M., & Prince, L. S. (2018) · Journal of Innate Immunity · doi:10.1159/000494070 · Cited by 6
Two novel translocations disrupt the RUNX1 gene in acute myeloid leukemia
Dai, H., Xue, Y., Pan, J., et al. (2007) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2007.04.018 · Cited by 6
Mechanisms Controlling Hematopoiesis
Fiedler, K., & Brunner, C. (2012) · InTech eBooks · doi:10.5772/33749 · Cited by 10
“Besides the upregulation of other transcription factors, C/EBP forces granulocyte development additionally by transactivation of various genes, such as G-CSF receptor (Hohaus et al., 1995; Smith, L. T. et al., 1996) or myeloperoxidase (MPO) (Wang, W.”
BackgroundLee, D.-H., Yu, E., Aldahl, J., Yang, J., He, Y., Hooker, E., Le, V. L., Mi, J., Olson, A. W., Wu, H., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211153 · Cited by 6
“Reverse transcription was carried out following our previous report [58].”
MethodHikima, J.-I., Ohtani, M., Kondo, H., Hırono, I., Jung, T. S., & Aoki, T. (2010) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2010.10.003 · Cited by 4
Militi, S., Riccioni, R., Parolini, I., Sposi, N. M., Samoggia, P., Pelosi, E., Testa, U., & Peschle, C. (2000) · British Journal of Haematology · doi:10.1111/j.1365-2141.2000.02348.x · Cited by 4
“In the present study, we have evaluated IL-3R and GM-CSFR expression by using either anti-IL-3Ra or anti-GM-CSFRa mAbs or labelled ligands (either biotin IL-3 or PE-labelled GM-CSF).”
BackgroundInfluentialMyeloid leukemoid reaction after initial azacitidine therapy for chronic myelomonocytic leukemia
Hagino, T., Sato, T., Saga, R., Hidai, H., Murai, Y., Akiyama, H., & Motomura, S. (2022) · International Journal of Hematology · doi:10.1007/s12185-022-03422-9 · Cited by 4
“1 and C/EBPα upregulate their targets G-CSF receptor and GM-CSF receptor [25, 26], suggesting an indirect mechanism of AZA to promote myeloid differentiation.”
BackgroundYamamoto, C. M., Banaei, N., Yount, N. Y., Patel, B., & Selsted, M. E. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0803384 · Cited by 4
Wang, G., Zhang, D., He, Z., Mao, B., Hu, X., Chen, L., Yang, Q., Zhou, Z., Zhang, Y., Linghu, K., et al. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012877 · Cited by 3
“Transcription factors (TFs) such as PU.1, C/EBPα, and Gfi-1 have been identified as vital in neutrophil differentiation [4–6].”
Decreased PU.1 expression in mature B cells induces lymphomagenesis
Endo, S., Nishimura, N., Toyoda, K., Komohara, Y., Carreras, J., Yuki, H., Shichijo, T., Ueno, S., Ueno, N., Hirata, S., et al. (2024) · Cancer Science · doi:10.1111/cas.16344 · Cited by 3
The versatile landscape of haematopoiesis: Are leukaemia stem cells as versatile?
Brown, G., Hughes, P., & Ceredig, R. H. (2012) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.742487 · Cited by 3
Type 1 interferon perturbates clonal competition by reshaping human blood development
Lama, C., Isakov, D., Rosenberg, S., Quijada-Álamo, M., Saurty-Seerunghen, M. S., Moein, S., Nozais, M., Abera, T.-A., Sakaguchi, O., Totwani, M., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02751-3 · Cited by 3
PU.1, a Versatile Transcription Factor and a Suppressor of Myeloid Leukemia
Takahashi, S. (2011) · InTech eBooks · doi:10.5772/25853 · Cited by 3
“Notable target genes are receptors for the cytokines, macrophage colony-stimulating factor (M-CSF), granulocyte colony-stimulating factor (G-CSF) and granulocyte macrophage colony-stimulating factor (GM-CSF) (Hohaus et al., 1995; Smith et al., 1996; Zhang et al., 1994), the characteristic antigens CD11b/CD18 (Rosmarin…”
BackgroundInfluentialStem Cell Differentiation Base on Acoustic Wave Sensor
Shih, C.-J., Kau, N.-H., & Tsai, B.-C. (2007) · IEEE International Conference on Nano/Micro Engineered and Molecular Systems · doi:10.1109/nems.2007.352096 · Cited by 2
RNA activation of CEBPA improves leukemia treatment
Kovecses, O., Sharif-Askari, B., González‐Losada, C., Reebye, V., Ryan, B. M., Kwok, A., Habib, N., Luedtke, N. W., Mercier, F., & McKeague, M. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102611 · Cited by 1
“…(transcription of p21, 10 repression of E2F, 13 and suppression of c-Myc 15 ) and promotes terminal myeloid differentiation 16,17 by upregulating myeloid-specific TFs 18 (e.g., PU.1 19,20 and CEBP ε 21,22 ) and genes encoding colony-stimulating factor receptors (e.g., CSF3R 23–25 and CSF2RA 26 ) .”
Bashir, H. S., Binod, G. C., Rahman, A. A., & Dong, F. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf159 · Cited by 1
Mallorson, R., Miyagi, E., Kao, S., Sukegawa, S., Saito, H., Fábryová, H., Ruggieri, L. M., Mediouni, S., Valente, S. T., & Strebel, K. (2023) · Journal of Virology · doi:10.1128/jvi.01702-23 · Cited by 1
“Altogether, we conclude that the transfer of the PU.”
BackgroundThe role of transcription factors in eosinophil differentiation
Baltus, G. E. (2002) · Utrecht University Repository (Utrecht University)
Analysis of senescence-like growth arrest induced by RUNX1 and its fusion derived oncoproteins
Wolyniec, K. (2008) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.578
Schwanke, R. C. (2008) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Proteinase 3 and Neutrophil Apoptosis in ANCA-Associated Systemic Vasculitis
Abdgawad, M. (2010) · Lund University Publications (Lund University)
CEBPA (CCAAT enhancer binding protein alpha)
Smith, L. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/38341
ETS transcription factor knockouts: A review
Bassuk, A. G. (1999) · Clinical Immunology Newsletter · doi:10.1016/s0197-1859(00)89197-9
LaVallee, T. M., & Morrison, S. L. (1996) · Molecular Immunology · doi:10.1016/s0161-5890(96)00036-3
Pieters, K. (2005) · Lund University Publications (Lund University)
INTERPLAY OF EXTRINSIC AND INTRINSIC CUES IN CELL-FATE DECISIONS
Palani, S. (2010) · ScholarlyCommons (University of Pennsylvania)
Real, D. (2013) · CaltechTHESIS (California Institute of Technology) · doi:10.7907/pews-km18
the t(8;21) Fusion Protein Neurofibromatosis-1 Tumor Suppressor by Transcriptional Repression of the
Hiebert, S. W., Gutmann, D. H., Delwel, R., Clapp, D. W., Gao, M., Khalaf, W. F., & van de Locht, L. T. (2014)
THE BIOLOGICAL FUNCTION OF INTERACTING PARTNERS OF ZXD FAMILY PROTEINS
Koneni, R. (2009) · EngagedScholarship @ Cleveland State University (Cleveland State University)
Transcription factor regulation of T helper subset function
Awe, O. (2015) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1724
DOCTEUR DE L'UNIVERSITE LOUIS PASTEUR
Moleculaire, B. (1995)
Stem Cells and Hematopoietic Cell Engineering
Xie, X., Li, Y., Sun, Y., Zhang, J. C., Fang, F., Yue, W., & Pei, X. (2015) · Translational medicine research · doi:10.1007/978-94-017-7273-0_5
Suarez-Martinez, J. E. (2016) · Michigan State University Libraries · doi:10.25335/m5pt9z
Functional analysis of epithelium-specific Ets transcription factor-1 in inflammation
Lee, C. M. (2016) · TSpace (University of Toronto)
The ontogeny of inflammatory macrophages and monocyte-derived dendritic cells
Menezes, S. (2017) · Research Portal (King's College London)
Gene Repression and Cell Cycle Regulation by PU.1 in Acute Myeloid Leukemia
Ziliotto, R. G. (2013) · Scholarship@Western (Western University)
Shamsasenjan, K., Timari, H., & Saleh, M. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101462
10.1016/b978-1-4557-5414-4.00001-2
(2000) · Time to knit · doi:10.1016/b978-1-4557-5414-4.00001-2
Gene Expression Imaging in Hematopoiesis
Wheat, J. C., Coleman, R. A., & Steidl, U. G. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169545
Regulation of Neutrophil Proteinases
Sturrock, A., & Hoidal, J. R. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8831-8_6
Sonn, I., Honda‐Ozaki, F., Yoshimatsu, S., Morimoto, S., Watanabe, H., & Okano, H. (2022) · Figshare · doi:10.6084/m9.figshare.20208350
Additional file 1 of Transcriptionally imprinted glycomic signatures of acute myeloid leukemia
Blöchl, C., Wang, D., Mayboroda, O. A., Lageveen‐Kammeijer, G. S. M., & Wuhrer, M. (2024) · Figshare · doi:10.6084/m9.figshare.26568559
Additional file 2 of Transcriptionally imprinted glycomic signatures of acute myeloid leukemia
Blöchl, C., Wang, D., Mayboroda, O. A., Lageveen‐Kammeijer, G. S. M., & Wuhrer, M. (2024) · Figshare · doi:10.6084/m9.figshare.26568562
Lewis, D. A., Shook, M., Lawson, L. P., Parameswaran, S., Chen, X., Edsall, L., Donmez, O. A., Yin, C., Rosado‐Tristani, D. A., VonHandorf, A., et al. (2026) · medRxiv · doi:10.64898/2026.01.26.26344838
Terret-Guéry, L. (2010) · theses.fr (ABES) · doi:10.70675/005598efzec21z43f2zb22ez300245496e37
Fernandez, É. M. (2012) · theses.fr (ABES) · doi:10.70675/57ccc5b2ze8faz494cz9447z61d356e2eb29
Jun regulates monocyte-derived macrophage accumulation and tumour progression
Delfini, M. (2019) · theses.fr (ABES) · doi:10.70675/afce218czd47fz4e81za3d3z2d2a848304d4
Roos‐Weil, D. (2018) · theses.fr (ABES) · doi:10.70675/1030cb13z12b8z4f7cz8f8az165206a6209a
Pereira-Abrantes, M. (2023) · theses.fr (ABES) · doi:10.70675/9966b97fz01d9z430dzb93dzb43bababd470
Bcl11b dose-dependently regulates positive selection of CD8 T cells to the virtual memory fatePreprint
Sidwell, T., & Rothenberg, E. V. (2026) · eLife · doi:10.64898/2026.07.03.731744
Ramani, M., Nguyen, N., Solis, J., Tenen, D. G., & Trinh, B. Q. (2026) · Biology · doi:10.3390/biology15181657
“Classical PU.1 target genes include cytokine receptor loci such as CSF1R (M-CSF receptor) [43,63], CSF2RA (GM-CSF receptor α ) [63,64], and CSF3R (G-CSF receptor) [63,65].”
Metadata
- Authors
- Hohaus, S., Petrovick, M. S., Voso, M. T., Sun, Z., Zhang, D.-E., & Tenen, D. G.
- Affiliations
- Harvard University (US)
- Corresponding author
- Tenen, Daniel G.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1995-10-01
- Volume
- 15
- Issue
- 10
- Pages
- 5830-5845
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC230835
- OpenAlex
- W2161743101
- Cited by
- 284
- References
- 73
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 5 · 2022: 8 · 2021: 3 · 2020: 6 · 2019: 6 · 2018: 7 · 2017: 5 · 2016: 5 · 2015: 8 · 2014: 5 · 2013: 7 · 2012: 6
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Funders
- American Lung Association
- National Cancer Institute (CA 41456, R01CA041456)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK048660, DK48660)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- PU.1, SPI-1, C/EBPα, GM-CSF receptor alpha, transcription factor binding sites, myelomonocytic cells, B cells, promoter regulation, transcriptional activation, hematopoiesis, single-stranded DNA binding, U937 cells
- MeSH terms
- Amino Acid Sequence, B-Lymphocytes, Base Sequence, Cell Line, DNA, DNA-Binding Proteins, DNA, Single-Stranded, Hematopoiesis, Humans, Methylation, Molecular Sequence Data, Monocytes, Mutation, Nuclear Proteins, Promoter Regions, Genetic, T-Lymphocytes, Transcription Factors, Transcriptional Activation, Retroviridae Proteins, Oncogenic, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor, Genes, Reporter, CCAAT-Enhancer-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
